{"text": "of Clinical Psychopharmacology, approximately 0.1% of patients taking Abilify\n\nexperience suicidal thoughts or behaviors (2). It is essential for patients and\n\ntheir families to be aware of this potential side effect and seek immediate\n\nmedical attention if they experience any symptoms.\n\nNeuroleptic Malignant Syndrome (NMS)\n\nAbilify may increase the risk of neuroleptic malignant syndrome (NMS), a rare\n\nbut serious side effect. According to a study published in the Journal of", "embedding": []}